Company: INMB
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001213900-25-021719
Chunk: 26

Company: Inmune Bio, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 26
---

of our securities are urged to obtain current information as to the market prices of our securities, where applicable.

We may offer the securities directly or through
agents or to or through underwriters or dealers. If any agents or underwriters are involved in the sale of the securities their names,
and any applicable purchase price, fee, commission or discount arrangement between or among them, will be set forth, or will be calculable
from the information set forth, in an accompanying prospectus supplement. We can sell the securities through agents, underwriters or dealers
only with delivery of a prospectus supplement describing the method and terms of the offering of such securities. See “Plan of Distribution.”

The aggregate market value of our outstanding
common stock held by non-affiliates was approximately $132.2 million which was calculated based on 19,782,429 shares of outstanding common
stock held by non-affiliates as of July 30, 2024, and a price per share of $9.86, the closing price of our common stock on July 16, 2024.

Investing in our securities involves significant risks. We strongly recommend that you read carefully the risks we describe in this prospectus and in any accompanying prospectus supplement, as well as the risk factors that are incorporated by reference into this prospectus from our filings made with the Securities and Exchange Commission. See “Risk Factors” beginning on page 5 of this prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>This prospectus is dated August 7, 2024

S-13

Table of Contents</div>

|                                                           |     | Page |
| ABOUT THIS PROSPECTUS                                     |     |   ii |
| CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS |     |  iii |
| PROSPECTUS SUMMARY                                        |     |    1 |
| RISK FACTORS                                              |     |    5 |
| USE OF PROCEEDS                                           |     |    6 |
| DESCRIPTION OF CAPITAL STOCK                              |     |    7 |
| DESCRIPTION OF WARRANTS                                   |     |    9 |
| DESCRIPTION OF UNITS                                      |     |   10 |
| PLAN OF DISTRIBUTION                                      |     |   10 |
| LEGAL MATTERS                                             |     |   13 |
| EXPERT